| 1 |
Research progress of the CXCR4 mechanism in Alzheimer's disease |
|
|
| Qiu-Lin Wang, Chang-Le Fang, Xue-Yan Huang, Lu-Lu Xue |
|
| Ibrain. 2022; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 2 |
A Comprehensive Investigation of Molecular Signatures and Pathways
Linking Alzheimer’s Disease and Epilepsy via Bioinformatic Approaches |
|
|
| Jiao Wu, Shu Zhu, Chenyang Zhao, Xiaoxue Xu |
|
| Current Alzheimer Research. 2022; 19(2): 146 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 3 |
Ligand-based Modeling of CXC Chemokine Receptor 4 and Identification
of Inhibitors of Novel Chemotypes as Potential Leads towards New Anti-
COVID-19 Treatments |
|
|
| Safa Daoud, Mutasem Taha |
|
| Medicinal Chemistry. 2022; 18(8): 871 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 4 |
Vascular Endothelial Growth Factor as a Potential Biomarker of Neuroinflammation and Frontal Cognitive Impairment in Patients with Alcohol Use Disorder |
|
|
| Nerea Requena-Ocaña, María Flores-Lopez, Esther Papaseit, Nuria García-Marchena, Juan Jesús Ruiz, Jesús Ortega-Pinazo, Antonia Serrano, Francisco Javier Pavón-Morón, Magí Farré, Juan Suarez, Fernando Rodríguez de Fonseca, Pedro Araos |
|
| Biomedicines. 2022; 10(5): 947 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 5 |
Targeting CXCR4 and CD47 Receptors: An Overview of New and Old Molecules for a Biological Personalized Anticancer Therapy |
|
|
| Manuela Leo, Lina Sabatino |
|
| International Journal of Molecular Sciences. 2022; 23(20): 12499 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 6 |
CXCR4 inhibition with AMD3100 attenuates amphetamine induced locomotor activity in adolescent Long Evans male rats |
|
|
| Briana Mason,Corey Calhoun,Victoria Woytowicz,Latifa Pina,Roshninder Kanda,Curtis Dunn,Antonio Alves,S. Tiffany Donaldson,Pavel I. Ortinski |
|
| PLOS ONE. 2021; 16(3): e0247707 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 7 |
PLCG2 rs72824905 Variant Reduces the Risk of Alzheimer’s Disease and Multiple Sclerosis |
|
|
| Fan Chen, Yan Zhang, Longcai Wang, Tao Wang, Zhifa Han, Haihua Zhang, Shan Gao, Yang Hu, Guiyou Liu |
|
| Journal of Alzheimer's Disease. 2021; 80(1): 71 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 8 |
PathwayMultiomics: An R Package for Efficient Integrative Analysis of Multi-Omics Datasets With Matched or Un-matched Samples |
|
|
| Gabriel J. Odom, Antonio Colaprico, Tiago C. Silva, X. Steven Chen, Lily Wang |
|
| Frontiers in Genetics. 2021; 12 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 9 |
At the bench: Pre-clinical evidence for multiple functions of CXCR4 in cancer |
|
|
| Gary D Luker,Jinming Yang,Ann Richmond,Stefania Scala,Claudio Festuccia,Margret Schottelius,Hans-Jürgen Wester,Johann Zimmermann |
|
| Journal of Leukocyte Biology. 2020; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 10 |
Postsynaptic damage and microglial activation in AD patients could be linked CXCR4/CXCL12 expression levels |
|
|
| Cristina Sanfilippo, Paola Castrogiovanni, Rosa Imbesi, Giuseppe Nunnari, Michelino Di Rosa |
|
| Brain Research. 2020; 1749: 147127 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 11 |
Insights from RNA-Seq analysis of Alzheimeræs data suggest upregulation of GPCRs |
|
|
| Amit Chaudhary,Shikha Kushwah,Neha Shree Maurya,Ashutosh Mani |
|
| Gene Reports. 2020; 21: 100921 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 12 |
Epigenetic effects of paternal cocaine on reward stimulus behavior and accumbens gene expression in mice |
|
|
| Alexandra M. Yaw,Rebecca A. Prosser,Piet C. Jones,Benjamin J. Garcia,Daniel A. Jacobson,J. David Glass |
|
| Behavioural Brain Research. 2019; 367: 68 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 13 |
Data-Driven Analysis of Age, Sex, and Tissue Effects on Gene Expression Variability in Alzheimeræs Disease |
|
|
| Lavida R. K. Brooks,George I. Mias |
|
| Frontiers in Neuroscience. 2019; 13 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 14 |
Patent highlights February–March 2019 |
|
|
| Hermann AM Mucke |
|
| Pharmaceutical Patent Analyst. 2019; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
